VKH
INFI

Virtu KCG Holdings’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Virtu KCG Holdings’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$96K Buy
60,844
+47,181
+345% +$91K ﹤0.01% 2426
2017
Q1 		$44K Buy
+13,663
New +$33.6K ﹤0.01% 2867
2016
Q4 		– Sell
-47,984
Closed -$75K – 3906
2016
Q3 		$75K Buy
47,984
+2,498
+5% +$3.84K ﹤0.01% 2713
2016
Q2 		$60K Buy
45,486
+5,915
+15% +$27.7K ﹤0.01% 2641
2016
Q1 		$209K Buy
+39,571
New +$242K 0.01% 2064
2015
Q2 		– Sell
-11,648
Closed -$163K – 3874
2015
Q1 		$163K Buy
+11,648
New +$178K ﹤0.01% 2491

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Virtu KCG Holdings's INFI Position: Q2 2017 in Review

Virtu KCG Holdings increased its Infinity Pharmaceuticals, Inc. (INFI) stake by 345% in Q2 2017, buying an estimated $91K and bringing the position to 60,844 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #2426.

Virtu KCG Holdings first reported a position in INFI in Q1 2015 and has held it in 6 quarters since. The position peaked at $209K in Q1 2016. 74 funds tracked by Wall St. Rank hold INFI as of Q2 2017.

  • Virtu KCG Holdings held 60,844 shares of Infinity Pharmaceuticals, Inc. worth $96K as of Q2 2017.
  • Virtu KCG Holdings bought 47,181 Infinity Pharmaceuticals, Inc. shares in Q2 2017, an estimated $91K.
  • Infinity Pharmaceuticals, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2426 holding.
  • Virtu KCG Holdings first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and has held it in 6 quarters since.
  • Virtu KCG Holdings's Infinity Pharmaceuticals, Inc. position peaked at $209K in Q1 2016.
  • 74 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.